Large-scale testing (Phase 3)Study completedNCT05375929What this trial is testingLearn About Abrocitinib Tablets in People With Atopic Dermatitis in IndiaWho this might be right forAtopic Dermatitis Pfizer 200
Large-scale testing (Phase 3)Study completedNCT02595073What this trial is testingClinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic DermatitisWho this might be right forAtopic Dermatitis Sun Pharmaceutical Industries, Inc. 124
Large-scale testing (Phase 3)Study completedNCT00691262What this trial is testingStudy to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic DermatitisWho this might be right forDermatitis, Atopic Astellas Pharma Inc 166
Large-scale testing (Phase 3)Not Yet RecruitingNCT07823595What this trial is testingAbrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of AgeWho this might be right forAtopic Dermatitis Pfizer 90
Not applicableActive Not RecruitingNCT05081557What this trial is testingAssess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic DermatitisWho this might be right forAtopic Dermatitis AbbVie 873
Not applicableUnknownNCT03962387What this trial is testingEvalution the Safety and Efficacy in Atopic Dermatitis PatientsWho this might be right forAtopic Dermatitis Kang Stem Biotech Co., Ltd. 98
Testing effectiveness (Phase 2)Study completedNCT04162899What this trial is testingA Phase II Study in Adult Patients With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis Reistone Biopharma Company Limited 105
Large-scale testing (Phase 3)Study completedNCT06554847What this trial is testingEvaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic DermatitisWho this might be right forDermatitis, AtopicEczema, Atopic Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 417
Large-scale testing (Phase 3)Looking for participantsNCT06807268What this trial is testingThe Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe EczemaWho this might be right forEczema Pfizer 150
Early research (Phase 1)UnknownNCT06175143What this trial is testingEvaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis.Who this might be right forAtopic Dermatitis Genrix (Shanghai) Biopharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07297602What this trial is testingEvaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot StudyWho this might be right forAtopic Dermatitis Nora Mohamed Abdelrazik 36
Testing effectiveness (Phase 2)Study completedNCT04805411What this trial is testingSubcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)Who this might be right forModerate-to-severe Atopic Dermatitis Keymed Biosciences Co.Ltd 120
Large-scale testing (Phase 3)Looking for participantsNCT07370909What this trial is testingEvaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic DermatitisWho this might be right forModerate to Severe Atopic Dermatitis Shanghai Longwood Biopharmaceuticals Co., Ltd. 480
Testing effectiveness (Phase 2)Study completedNCT03822832What this trial is testingA Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is ToleratedWho this might be right forDermatitis, Atopic Boehringer Ingelheim 51
Large-scale testing (Phase 3)Study completedNCT03912259What this trial is testingEvaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis Sanofi 165
Large-scale testing (Phase 3)Active Not RecruitingNCT06701331What this trial is testingSafety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis AbbVie 99
Not applicableUnknownNCT03795506What this trial is testingTLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)Who this might be right forAtopic Dermatitis Eczema Imperial College London 96
Large-scale testing (Phase 3)Study completedNCT05990725What this trial is testingEffectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic DermatitisWho this might be right forAtopic DermatitisEczema Almirall, S.A. 260
Testing effectiveness (Phase 2)Study completedNCT02594098What this trial is testingSecukinumab for Treatment of Atopic DermatitisWho this might be right forAtopic Dermatitis Icahn School of Medicine at Mount Sinai 41
Testing effectiveness (Phase 2)Study completedNCT04684485What this trial is testingTo Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic DermatitisWho this might be right forDermatitis, Atopic Sun Pharmaceutical Industries Limited 250